Market-Moving News for April 18th
Market-Moving News for April 18th
BPTH: 98% | Bio-Path Holdings shares are trading higher after the company announced the completion of its second dose cohort in Phase 1/1b clinical trial of BP1002 evaluating the ability of BP1002 to treat refractory/relapsed acute myeloid leukemia patients
BPTH：98% | Bio-Path Holdings的股价上涨，此前该公司宣布完成了评估BP1002 治疗难治性/复发急性髓系白血病患者的能力的1/1b期临床试验，其第二剂量队列已完成 BP1002
THCH: 47% | TH International shares are trading higher after the company reported a year-over-year increase in Q4 financial results.
四氢大麻酚：47％ | TH International报告第四季度财务业绩同比增长后，该公司股价上涨。
BNTC: 60% | Benitec Biopharma shares are trading higher. The company announced a $40 million oversubscribed private placement financing and reported interim clinical data for the first OPMD subject treated with BB-301 in its Phase 1b/2a study.
BNTC：60% | 贝尼特克生物制药公司股价走高。该公司宣布了4000万澳元的超额认购私募融资，并在其1b/2a期研究中报告了首位接受 BB-301 治疗的OPMD受试者的中期临床数据。